The New Orleans BioInnovation Center is a $48 million facility that partners with LSUHSC and Tulane to support the commercialization of biotechnologies in the region. It provides lab space, funding assistance, and business programming to 50 technology companies. Examples include NuMe Health, which is developing prebiotics for health conditions, and MiniVax, which received an NIH grant for vaccine development. The Center aims to continue growing the entrepreneurial culture and research base in the region while addressing challenges around workforce, capital, and retaining startup companies.
Pitches from the 10 finalist teams selected to compete for the £100,000 Grand Prize of the inaugural OneStart competition in 2013, hosted by the Oxbridge Biotech Roundtable and SR One.
Learn more about this year's competition: http://oxbridgebiotech.com/onestart
https://www.facebook.com/handicorp
HandICorp contracts inventors across different fields and transforms their creations into new products for the industry based on global consumer opinions with the help of online and offline services to let:
- Consumers voice their pain points.
- Industries seek their future products.
- Inventors monetize their unique creations.
Pitches from the 10 finalist teams selected to compete for the £100,000 Grand Prize of the inaugural OneStart competition in 2013, hosted by the Oxbridge Biotech Roundtable and SR One.
Learn more about this year's competition: http://oxbridgebiotech.com/onestart
https://www.facebook.com/handicorp
HandICorp contracts inventors across different fields and transforms their creations into new products for the industry based on global consumer opinions with the help of online and offline services to let:
- Consumers voice their pain points.
- Industries seek their future products.
- Inventors monetize their unique creations.
MEDTECH 2013: Morning Plenary, Roger Kitterman, Managing Partner of Innovatio...MedTechAssociation
Roger Kitterman, Managing Partner of Innovation Fund, Partners Healthcare, presents at MEDTECH 2013 on October 8, 2013 on Trends in Early Stage Medical Technologies: A Venture Perspective.
New Orleans BioInnovation Center 2016 Annual Reportneworleansbio
Introducing the 2016 Annual Report from the New Orleans BioInnovation Center, highlighting the organization's programs for Louisiana life science entrepreneurs and growing impact on the regional economy. A nonprofit business incubator opened in 2011, the Center has worked with more than 125 startups that have raised over $90 million in funding and created nearly 400 jobs. Tenants and clients supported by our program teams include startups developing innovative new medical devices, therapeutics, diagnostics, digital health platforms, clean technologies, and more. These technologies range from cancer and diabetes treatments to urban farming and water remediation solutions. All promise to improve global health. Learn more at www.neworleansbio.com.
An interactive , web based tool which is future-oriented and adaptive to incorporate new learning.
Bespoke software and knowledge base designed as a guide to the translation of scientific discoveries into usable technologies and therapies.
User friendly system easy to use with download and upload capabilities to create customised reports.
By: Fiona Fitzgerald, GE Healthcare Canada
At Sherbrooke International Life Sciences Summit - 2nd edition | September 28/29/30 2015
www.sils-sherbrooke.com
The New Orleans BioInnovation Center presents the annual Innovation Louisiana Conference on forming, funding, and growing a bioscience startup featuring national industry experts and investors. Through panel discussions and keynotes by national experts, the conference educates life science entrepreneurs, university researchers, students, and the business community on technology innovation issues. Get educated and inspired as you work to move breakthroughs from the lab to the market. Don’t miss this important opportunity to learn about key issues from finding funding for development and commercialization to successfully introducing innovations in a clinical setting.
Mc carter enabling innovation washu 11.7.14James McCarter
The Washington University Monsanto Graduate Fellows' Symposium on November 7th, 2014 fostered interaction between academia, industry, & entrepreneurship. Jim McCarter, Senior EIR at BioGenerator & Adjunct Professor of Genetics provided a quick tour of resources for start-ups at WashU & in St. Louis.
Our Mission: Launching & growing new Israeli biotech companies developing innovative protein-based biotherapeutics from early stage to late-clinical phase
MEDTECH 2013: Morning Plenary, Roger Kitterman, Managing Partner of Innovatio...MedTechAssociation
Roger Kitterman, Managing Partner of Innovation Fund, Partners Healthcare, presents at MEDTECH 2013 on October 8, 2013 on Trends in Early Stage Medical Technologies: A Venture Perspective.
New Orleans BioInnovation Center 2016 Annual Reportneworleansbio
Introducing the 2016 Annual Report from the New Orleans BioInnovation Center, highlighting the organization's programs for Louisiana life science entrepreneurs and growing impact on the regional economy. A nonprofit business incubator opened in 2011, the Center has worked with more than 125 startups that have raised over $90 million in funding and created nearly 400 jobs. Tenants and clients supported by our program teams include startups developing innovative new medical devices, therapeutics, diagnostics, digital health platforms, clean technologies, and more. These technologies range from cancer and diabetes treatments to urban farming and water remediation solutions. All promise to improve global health. Learn more at www.neworleansbio.com.
An interactive , web based tool which is future-oriented and adaptive to incorporate new learning.
Bespoke software and knowledge base designed as a guide to the translation of scientific discoveries into usable technologies and therapies.
User friendly system easy to use with download and upload capabilities to create customised reports.
By: Fiona Fitzgerald, GE Healthcare Canada
At Sherbrooke International Life Sciences Summit - 2nd edition | September 28/29/30 2015
www.sils-sherbrooke.com
The New Orleans BioInnovation Center presents the annual Innovation Louisiana Conference on forming, funding, and growing a bioscience startup featuring national industry experts and investors. Through panel discussions and keynotes by national experts, the conference educates life science entrepreneurs, university researchers, students, and the business community on technology innovation issues. Get educated and inspired as you work to move breakthroughs from the lab to the market. Don’t miss this important opportunity to learn about key issues from finding funding for development and commercialization to successfully introducing innovations in a clinical setting.
Mc carter enabling innovation washu 11.7.14James McCarter
The Washington University Monsanto Graduate Fellows' Symposium on November 7th, 2014 fostered interaction between academia, industry, & entrepreneurship. Jim McCarter, Senior EIR at BioGenerator & Adjunct Professor of Genetics provided a quick tour of resources for start-ups at WashU & in St. Louis.
Our Mission: Launching & growing new Israeli biotech companies developing innovative protein-based biotherapeutics from early stage to late-clinical phase
Mechanisms for bringing together a broad range of stakeholders that share common interests in product
innovation to increase the number of impactful therapies for skin diseases such as alopecia areata.
Program from the Innovation Louisiana 2013 life sciences entrepreneurship conference, presented by the New Orleans BioInnovation Center. Featuring sessions on startup funding, legal issues for growth startups, technology transfer, and other issues affecting life sciences startups
The Roman Empire A Historical Colossus.pdfkaushalkr1407
The Roman Empire, a vast and enduring power, stands as one of history's most remarkable civilizations, leaving an indelible imprint on the world. It emerged from the Roman Republic, transitioning into an imperial powerhouse under the leadership of Augustus Caesar in 27 BCE. This transformation marked the beginning of an era defined by unprecedented territorial expansion, architectural marvels, and profound cultural influence.
The empire's roots lie in the city of Rome, founded, according to legend, by Romulus in 753 BCE. Over centuries, Rome evolved from a small settlement to a formidable republic, characterized by a complex political system with elected officials and checks on power. However, internal strife, class conflicts, and military ambitions paved the way for the end of the Republic. Julius Caesar’s dictatorship and subsequent assassination in 44 BCE created a power vacuum, leading to a civil war. Octavian, later Augustus, emerged victorious, heralding the Roman Empire’s birth.
Under Augustus, the empire experienced the Pax Romana, a 200-year period of relative peace and stability. Augustus reformed the military, established efficient administrative systems, and initiated grand construction projects. The empire's borders expanded, encompassing territories from Britain to Egypt and from Spain to the Euphrates. Roman legions, renowned for their discipline and engineering prowess, secured and maintained these vast territories, building roads, fortifications, and cities that facilitated control and integration.
The Roman Empire’s society was hierarchical, with a rigid class system. At the top were the patricians, wealthy elites who held significant political power. Below them were the plebeians, free citizens with limited political influence, and the vast numbers of slaves who formed the backbone of the economy. The family unit was central, governed by the paterfamilias, the male head who held absolute authority.
Culturally, the Romans were eclectic, absorbing and adapting elements from the civilizations they encountered, particularly the Greeks. Roman art, literature, and philosophy reflected this synthesis, creating a rich cultural tapestry. Latin, the Roman language, became the lingua franca of the Western world, influencing numerous modern languages.
Roman architecture and engineering achievements were monumental. They perfected the arch, vault, and dome, constructing enduring structures like the Colosseum, Pantheon, and aqueducts. These engineering marvels not only showcased Roman ingenuity but also served practical purposes, from public entertainment to water supply.
Biological screening of herbal drugs: Introduction and Need for
Phyto-Pharmacological Screening, New Strategies for evaluating
Natural Products, In vitro evaluation techniques for Antioxidants, Antimicrobial and Anticancer drugs. In vivo evaluation techniques
for Anti-inflammatory, Antiulcer, Anticancer, Wound healing, Antidiabetic, Hepatoprotective, Cardio protective, Diuretics and
Antifertility, Toxicity studies as per OECD guidelines
Welcome to TechSoup New Member Orientation and Q&A (May 2024).pdfTechSoup
In this webinar you will learn how your organization can access TechSoup's wide variety of product discount and donation programs. From hardware to software, we'll give you a tour of the tools available to help your nonprofit with productivity, collaboration, financial management, donor tracking, security, and more.
Acetabularia Information For Class 9 .docxvaibhavrinwa19
Acetabularia acetabulum is a single-celled green alga that in its vegetative state is morphologically differentiated into a basal rhizoid and an axially elongated stalk, which bears whorls of branching hairs. The single diploid nucleus resides in the rhizoid.
Instructions for Submissions thorugh G- Classroom.pptxJheel Barad
This presentation provides a briefing on how to upload submissions and documents in Google Classroom. It was prepared as part of an orientation for new Sainik School in-service teacher trainees. As a training officer, my goal is to ensure that you are comfortable and proficient with this essential tool for managing assignments and fostering student engagement.
Synthetic Fiber Construction in lab .pptxPavel ( NSTU)
Synthetic fiber production is a fascinating and complex field that blends chemistry, engineering, and environmental science. By understanding these aspects, students can gain a comprehensive view of synthetic fiber production, its impact on society and the environment, and the potential for future innovations. Synthetic fibers play a crucial role in modern society, impacting various aspects of daily life, industry, and the environment. ynthetic fibers are integral to modern life, offering a range of benefits from cost-effectiveness and versatility to innovative applications and performance characteristics. While they pose environmental challenges, ongoing research and development aim to create more sustainable and eco-friendly alternatives. Understanding the importance of synthetic fibers helps in appreciating their role in the economy, industry, and daily life, while also emphasizing the need for sustainable practices and innovation.
Honest Reviews of Tim Han LMA Course Program.pptxtimhan337
Personal development courses are widely available today, with each one promising life-changing outcomes. Tim Han’s Life Mastery Achievers (LMA) Course has drawn a lot of interest. In addition to offering my frank assessment of Success Insider’s LMA Course, this piece examines the course’s effects via a variety of Tim Han LMA course reviews and Success Insider comments.
How to Make a Field invisible in Odoo 17Celine George
It is possible to hide or invisible some fields in odoo. Commonly using “invisible” attribute in the field definition to invisible the fields. This slide will show how to make a field invisible in odoo 17.
Palestine last event orientationfvgnh .pptxRaedMohamed3
An EFL lesson about the current events in Palestine. It is intended to be for intermediate students who wish to increase their listening skills through a short lesson in power point.
3. • $48 million LEED Gold Facility
• Formed under 2002 Legislation
• Part of a statewide network
(Shreveport, Baton Rouge, New
Orleans)
• LSUHSC/Tulane Partnership, with
focus on all New Orleans-based
universities
• Funded by LA Department of
Economic Development & DoC/EDA
4. Mission Statement
The mission of the New Orleans
BioInnovation Center is to provide
support and guidance to companies
commercializing biotechnologies in the
Greater New Orleans Area by facilitating
communications and promoting
entrepreneurial thinking.
10. Areas of Research
Expertise
• Infectious Diseases
• Cardiovascular
Disease/Hypertension
• Cancer Research & Treatments
• Neurosciences
• Obesity & Diabetes
11. Areas of Research
Expertise
• Biomedical Engineering
• Chemical Engineering
• Vaccines
• Peptides
• Drug Delivery
15. Capital Sources
Programming
Programming
• Partnerships
• Operations CEA
• BoR Grants
• Innovation Loan & Technical Assistance
• Delta Recovery Authority
• EDA (with GNO, Inc.
16. Programmin
g
• Inventor Interviews
(academic researchers, private entrepreneurs)
• Market Analyses
• Patent Searches
• Business Plan Creation
17. Programmin
g
• Financing Strategies
• Pitch Presentation Preparation
• SBIR/STTR Grant Application Support
• Economic Incentives
18. Programmin
g
• Seminars, Webinars, Workshops
• Identifying sources of capital
(SBIR/STTR grants, Angel, VC)
• Understanding Intellectual Property,
Patent Law Reform, Tax Credits
• Round-Table Discussions
• Networking Events/Conferences
• Perkin Mentors
19. Results
Total Technologies Actively Supported: 50
Entrepreneurs Interviewed: 71
SBIR/STTR Phase 0 Applications 8
SBIR/STTR Phase I/II Applications 15 (28)
5
SBIR/STTR Phase I Funded ~ $2.3
million
Equity-based funding $14 million
20. NuMe Health is developing evidence-based prebiotic products
designed to alter bacterial populations in the GI tract to prevent and
manage serious health conditions. NuMe's initial products and research
are focusing on pre-diabetes, diabetes and unhealthy body weight.
Innogenomics is a genomics solution provider focused on developing
and marketing next-generation genetic testing solutions for paternity
and forensic applications. InnoGenomics has secured a strong IP
position related to their platform technology and is currently in a
research and development phase to optimize a forensic DNA testing kit
that will facilitate the use of biological samples that are substantially
smaller and/or more degraded than the current industry standard to
analyze crime scene evidence.
MiniVax is currently developing therapeutic and preventative vaccines
for Pneumocystis carinii, a fungal pathogen that can cause severe, and
often fatal, lung infections especially in patients with HIV or other
conditions affecting the immune system. MiniVax was recently
awarded a $600,000 advanced technologies STTR research and
development grant by the NIH.
NanoFex has developed novel nanoparticle technology that provides an
affordable, effective method for remediating common, yet extremely
dangerous, pollutants in groundwater.
21. Bioceptive is a medical device startup built on a patent-pending
intrauterine device (IUD) inserter that minimizes complications
associated with currently used inserters and insertion techniques.
Bioceptive has recently taken on pre-seed funding through two
independent outside investment groups in order to fund further
prototype validation studies.
VoiceHIT is a web-based platform that uses predictive modeling and
3rd-party applications and devices to leverage the power of data to
prompt action, facilitate collaboration, and proactively manage health.
This creates a seamless platform that extends to 3rd-party applications
and mobile health devices, breaks down silos, and integrates data in
order to proactively prompt action by providers and patients alike. The
Better DayTM platform facilitates 100% patient focus, saving time and
improving care.
Wibi+Works is developing methods to improve the anti-inflammatory
properties of stem-cells for use in a variety of disease states, including
rheumatoid arthritis. The ability to create uniform cellular therapeutics
with predictable behavior is anticipated to significantly augment the
efficacy of mesenchymal stem-cell therapeutics addressing
inflammation-related disorders.
ReactWell is a next-generation oil company developing technology to
produce high-volume biomass-based crude oil and various other
valuable commodities. Our technology bridges proven geothermal
technology, aquaculture and biofuels. ReactWell transforms waste and
biomass into clean, sustainable, and cost-effective synthetic crude oil.
26. Challenges
• Continued Development of an
Entrepreneurial Culture
• Maintaining and Growing Current Research
Base
• Workforce / Experienced Management
• Retaining Incubator Graduates
• Capital
27. Near Term
Strategy
• Expand Reach into Business Community
• Increased National Coverage of Mission,
Clients, Partners
• Attract National/International Partners
• Expand Programming
• Form Advisory Committee
• Establish Graduation Facility
Background Facility description Programming Outline of services Current status Client Mix Technologies Stage of Development (a) Discussions of increases in start ups(b) Increases in services provided those start ups by organizations such as NOBIC, Idea Village, Launch Pad, new incubators, plans to increase those services in the future, etc.(c) The array of Federal, State and local government funding and incentives available to such start ups, with examples(d) The availability of management teams and increasing sophistication of those teams.(e) Increased availability of start-up capital, such as wealthy individuals, angel groups, debt funds such as the BioFund and out-of-state venture funds who are discovering the opportunities in Louisiana(f) Implicit conclusion: very good deal flow for LF II!
Background Facility description Programming Outline of services Current status Client Mix Technologies Stage of Development (a) Discussions of increases in start ups(b) Increases in services provided those start ups by organizations such as NOBIC, Idea Village, Launch Pad, new incubators, plans to increase those services in the future, etc.(c) The array of Federal, State and local government funding and incentives available to such start ups, with examples(d) The availability of management teams and increasing sophistication of those teams.(e) Increased availability of start-up capital, such as wealthy individuals, angel groups, debt funds such as the BioFund and out-of-state venture funds who are discovering the opportunities in Louisiana(f) Implicit conclusion: very good deal flow for LF II!
Background Facility description Programming Outline of services Current status Client Mix Technologies Stage of Development (a) Discussions of increases in start ups(b) Increases in services provided those start ups by organizations such as NOBIC, Idea Village, Launch Pad, new incubators, plans to increase those services in the future, etc.(c) The array of Federal, State and local government funding and incentives available to such start ups, with examples(d) The availability of management teams and increasing sophistication of those teams.(e) Increased availability of start-up capital, such as wealthy individuals, angel groups, debt funds such as the BioFund and out-of-state venture funds who are discovering the opportunities in Louisiana(f) Implicit conclusion: very good deal flow for LF II!
Background Facility description Programming Outline of services Current status Client Mix Technologies Stage of Development (a) Discussions of increases in start ups(b) Increases in services provided those start ups by organizations such as NOBIC, Idea Village, Launch Pad, new incubators, plans to increase those services in the future, etc.(c) The array of Federal, State and local government funding and incentives available to such start ups, with examples(d) The availability of management teams and increasing sophistication of those teams.(e) Increased availability of start-up capital, such as wealthy individuals, angel groups, debt funds such as the BioFund and out-of-state venture funds who are discovering the opportunities in Louisiana(f) Implicit conclusion: very good deal flow for LF II!